Ellie McGuire is a partner of the Polaris Innovation Fund.
McGuire currently serves on the Boards of Montis Biosciences, Candesant Biomedical, Satellite Biosciences, and Mellitus. In addition, she was the founding president of Volastra Therapeutics. She is an expert in residence for the Harvard Office of Technology Development and is on the Fred Hutch Evergreen Fund Advisory Committee.
Prior to co-founding the Polaris Innovation Fund, McGuire was the head of business development at Lyndra, where she was also a member of the founding team. She previously held leadership and consulting positions in business development, operations, and strategy in multiple life science companies including Arsia Therapeutics, Lyndra, and XTuit Pharmaceuticals.